Learn how the molecule EBC-46 could advance how HIV is treated and how researchers discovered it.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't ...

potentially contributing to a functional cure for HIV. Following this trial, Gilead has the exclusive right to further develop the program. We have seen 0 institutional investors add shares of ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

The stop-work order on USAID-funded research has left thousands of people with experimental drugs or devices in their bodies, ...

Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...

By targeting infected cells in the brain, drug may clear virus ... Proof-of-Concept Study to Find Functional Cure for HIV July 24, 2024 — Researchers conducted a breakthrough proof-of-concept ...

VICTORIA - Antiretroviral treatment has increased the life expectancy of people living with HIV in British Columbia but a new ...

announced on Thursday that enrollment has been completed in its Phase 1b clinical trial evaluating HB-500 for the treatment of HIV. The trial, which enrolled 30 participants across five U.S. sites ...

today announced that enrollment is complete in the Phase 1b clinical trial evaluating HB-500 for the treatment of HIV, with 30 participants enrolled across five sites in the United States.